Literature DB >> 21289597

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Ron T Gansevoort1, Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh.   

Abstract

Both a low estimated glomerular filtration rate (eGFR) and albuminuria are known risk factors for end-stage renal disease (ESRD). To determine their joint contribution to ESRD and other kidney outcomes, we performed a meta-analysis of nine general population cohorts with 845,125 participants and an additional eight cohorts with 173,892 patients, the latter selected because of their high risk for chronic kidney disease (CKD). In the general population, the risk for ESRD was unrelated to eGFR at values between 75 and 105 ml/min per 1.73 m(2) but increased exponentially at lower levels. Hazard ratios for eGFRs averaging 60, 45, and 15 were 4, 29, and 454, respectively, compared with an eGFR of 95, after adjustment for albuminuria and cardiovascular risk factors. Log albuminuria was linearly associated with log ESRD risk without thresholds. Adjusted hazard ratios at albumin-to-creatinine ratios of 30, 300, and 1000 mg/g were 5, 13, and 28, respectively, compared with an albumin-to-creatinine ratio of 5. Albuminuria and eGFR were associated with ESRD, without evidence for multiplicative interaction. Similar associations were found for acute kidney injury and progressive CKD. In high-risk cohorts, the findings were generally comparable. Thus, lower eGFR and higher albuminuria are risk factors for ESRD, acute kidney injury and progressive CKD in both general and high-risk populations, independent of each other and of cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289597      PMCID: PMC3959732          DOI: 10.1038/ki.2010.531

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  48 in total

1.  Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

Authors:  P Ruggenenti; A Perna; L Mosconi; R Pisoni; G Remuzzi
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

2.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

3.  Mortality risk stratification in chronic kidney disease: one size for all ages?

Authors:  Ann M O'Hare; Daniel Bertenthal; Kenneth E Covinsky; C Seth Landefeld; Saunak Sen; Kala Mehta; Michael A Steinman; Ann Borzecki; Louise C Walter
Journal:  J Am Soc Nephrol       Date:  2006-02-01       Impact factor: 10.121

4.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

5.  Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.

Authors:  Kunitoshi Iseki; Kozen Kinjo; Chiho Iseki; Shuichi Takishita
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

8.  Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey
Journal:  Ann Intern Med       Date:  2003-08-19       Impact factor: 25.391

9.  The role of specialists in managing the health of populations with chronic illness: the example of chronic kidney disease.

Authors:  Brian J Lee; Ken Forbes
Journal:  BMJ       Date:  2009-07-08

10.  Proteinuria and the risk of developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  292 in total

1.  Improvement in kidney function: a real occurrence.

Authors:  Tanvir Chowdhury Turin; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

2.  Estimated GFR, albuminuria, and complications of chronic kidney disease.

Authors:  Lesley A Inker; Josef Coresh; Andrew S Levey; Marcello Tonelli; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

3.  Chronic kidney disease: Albuminuria or CKD stage as best marker of CVD in diabetes?

Authors:  Judith Blaine; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2012-05-29       Impact factor: 28.314

4.  Past Decline Versus Current eGFR and Subsequent Mortality Risk.

Authors:  David M J Naimark; Morgan E Grams; Kunihiro Matsushita; Corri Black; Iefke Drion; Caroline S Fox; Lesley A Inker; Areef Ishani; Sun Ha Jee; Akihiko Kitamura; Janice P Lea; Joseph Nally; Carmen Alicia Peralta; Dietrich Rothenbacher; Seungho Ryu; Marcello Tonelli; Hiroshi Yatsuya; Josef Coresh; Ron T Gansevoort; David G Warnock; Mark Woodward; Paul E de Jong
Journal:  J Am Soc Nephrol       Date:  2015-12-11       Impact factor: 10.121

Review 5.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

6.  Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts.

Authors:  Chi-Yuan Hsu; Raymond K Hsu; Kathleen D Liu; Jingrong Yang; Amanda Anderson; Jing Chen; Vernon M Chinchilli; Harold I Feldman; Amit X Garg; Lee Hamm; Jonathan Himmelfarb; James S Kaufman; John W Kusek; Chirag R Parikh; Ana C Ricardo; Sylvia E Rosas; Georges Saab; Daohang Sha; Edward D Siew; James Sondheimer; Jonathan J Taliercio; Wei Yang; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2019-06-24       Impact factor: 10.121

7.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

8.  Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.

Authors:  Herrick Fisher; Chi-Yuan Hsu; Eric Vittinghoff; Feng Lin; Nisha Bansal
Journal:  Am J Kidney Dis       Date:  2013-09-14       Impact factor: 8.860

9.  Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.

Authors:  Salman Waheed; Kunihiro Matsushita; Brad C Astor; Ron C Hoogeveen; Christie Ballantyne; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

10.  Glomerular and tubular damage markers in individuals with progressive albuminuria.

Authors:  Ferdau L Nauta; Lieneke Scheven; Esther Meijer; Wim van Oeveren; Paul E de Jong; Stephan J L Bakker; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.